Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Emerging Concepts in Treating Triple-Negative Breast Cancer

EP. 1: Classification of Triple Negative Breast Cancer

February 15th 2018

EP. 2: Histologic Subtyping in TNBC

February 15th 2018

EP. 3: Germline BRCA Mutations in TNBC

February 15th 2018

EP. 4: NCCN Guideline Changes for BRCA Testing in TNBC

February 15th 2018

EP. 5: Sequencing in BRCA-Positive TNBC Patients

February 15th 2018

EP. 6: Combining PARP Inhibitors + Checkpoint Inhibitors in TNBC

February 15th 2018

EP. 7: Neoadjuvant Therapy in TNBC

February 15th 2018

EP. 8: Anthracycline-Based Regimens: Perioperative Setting for TNBC

February 15th 2018

EP. 9: No pCR in Patients After Neoadjuvant Chemotherapy in TNBC

February 15th 2018

EP. 10: Paclitaxel vs Nab-Paclitaxel in Metastatic TNBC

February 15th 2018

EP. 11: Antibody-Drug Conjugates in Treating TNBC

February 15th 2018

EP. 12: Checkpoint Inhibitor Monotherapy for TNBC

February 15th 2018

EP. 13: Combination Therapy for TNBC: Checkpoint Inhibitor + Chemotherapy

February 15th 2018

EP. 14: Role of the Androgen Receptor in TNBC

February 15th 2018

EP. 15: Other Promising Targets in TNBC

February 15th 2018
Advertisement
Advertisement

Trending on OncLive

1

Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg

2

Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC

3

Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL

4

ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC

5

HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us